An 85-year-old Japanese woman had noticed erythema on her vulvar region 3 years before. The erythema gradually increased in size and followed erosion and ulceration with pigmentation on the edge of the erythema. A skin biopsy from the pigmented area showed large round cells with ample cytoplasm, which formed nests or glandular structures. In the dermis there was mass formation of basophilic cells and peripheral cells in a palisade arrangement. The tumor cells in the epidermis showed positive immunoreactivity for carcinoembryonic antigen; on the other hand, the dermal tumor was negative. We diagnosed that the tumor in the epidermis was vulvar Paget’s disease, and the dermal tumor was a solid type of basal cell carcinoma. We speculate that the vulvar Paget’s disease preceded and then the basal cell carcinoma developed in the area of Paget’s disease. This is the first report in which basal cell carcinoma in the area of Paget’s disease was documented.

1.
Olbricht S, Noe JM: Cutaneous carcinomas; in Georgiade GS, Riefkohl R, Barwick W (eds): Textbook of Plastic, Maxillofacial and Reconstructive Surgery, ed 2. Baltimore, Williams & Wilkins, 1992, pp 141–147.
2.
Ono M: Basal cell carcinoma. Skin Cancer 1994;78:78–83.
3.
Palladino VS, Duffy JL, Bures GJ: Basal cell carcinoma of the vulva. Cancer 1969;24: 460–464.
4.
Schueller EF: Basal cell cancer of the vulva. Am J Obstet Gynecol 1965;93:199–202.
5.
Sturgeon SR, Brinton LA, Devesa SS, Kurman RJ: In situ and invasive vulvar cancer incidence trends (1973 to 1987). Am J Obstet Gynecol 1992;166:1482–1485.
6.
Paget J: Disease of the mammary areola preceding cancer of the mammary gland. St Bartholomew’s Hosp Res 1874;10:87–89.
7.
Ohara K, Onishi Y, Kawabata Y: Diagnosis and treatment of extramammary Paget’s disease. Skin Cancer 1993;8:187–208.
8.
Kikuchi O, Shimizu H, Harada T, Nishikawa T: Statistical analysis of 22 years of malignant skin tumors in Keio University Hospital. Jpn J Dermatol 1993;103:1743–1746.
9.
Lever WF, Schaumburg-Lever G: Histopathology of the Skin, ed 7. Philadelphia, Lippincott, 1990, pp 563–568.
10.
Landa NG, Winkelmann RK: Epidermotropically eccrine porocarcinoma. J Am Acad Dermatol 1991;24:27–31.
11.
Pinkus H, Mehregan AH: Epidermotropic eccrine carcinoma. Arch Dermatol 1963;88: 587–606.
12.
Wolfe JT III, Yeatts RP, Wick MR, Campbell RJ, Waller RR: Sebaceous carcinomas of the eyelid: Errors in clinical and pathological diagnosis. Am J Surg Pathol 1984;8:597–606.
13.
LeBoit PE, Crutcher WA, Shapiro PE: Pagetoid intraepidermal spread in Merkel cell (primary neuroendocrine) carcinoma of the skin. Am J Surg Pathol 1992;16:584–592.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.